Shell Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-724
| Closed | -$185K | – | 1480 |
|
|
2020
Q4 | $185K | Buy |
+724
| New | +$185K | ﹤0.01% | 1139 |
|
|
2019
Q4 | – | Sell |
-782
| Closed | -$214K | – | 1256 |
|
|
2019
Q3 | $214K | Hold |
782
| – | – | ﹤0.01% | 1117 |
|
|
2019
Q2 | $417K | Sell |
782
-37
| -5% | -$19.7K | 0.01% | 988 |
|
|
2019
Q1 | $413K | Hold |
819
| – | – | 0.01% | 985 |
|
|
2018
Q4 | $404K | Buy |
819
+97
| +13% | +$47.8K | 0.01% | 910 |
|
|
2018
Q3 | $661K | Sell |
722
-676
| -48% | -$619K | 0.01% | 873 |
|
|
2018
Q2 | $1.02M | Buy |
1,398
+47
| +3% | +$34.4K | 0.02% | 666 |
|
|
2018
Q1 | $2.15M | Sell |
1,351
-547
| -29% | -$872K | 0.04% | 380 |
|
|
2017
Q4 | $1.7M | Sell |
1,898
-1,509
| -44% | -$1.35M | 0.03% | 438 |
|
|
2017
Q3 | $1.23M | Hold |
3,407
| – | – | 0.03% | 521 |
|
|
2017
Q2 | $999K | Sell |
3,407
-191
| -5% | -$56K | 0.02% | 643 |
|
|
2017
Q1 | $1.27M | Sell |
3,598
-758
| -17% | -$267K | 0.03% | 516 |
|
|
2016
Q4 | $802K | Hold |
4,356
| – | – | 0.02% | 741 |
|
|
2016
Q3 | $1.12M | Buy |
4,356
+1,238
| +40% | +$319K | 0.02% | 599 |
|
|
2016
Q2 | $665K | Hold |
3,118
| – | – | 0.02% | 679 |
|
|
2016
Q1 | $643K | Hold |
3,118
| – | – | 0.02% | 623 |
|
|
2015
Q4 | $788K | Hold |
3,118
| – | – | 0.02% | 599 |
|
|
2015
Q3 | $564K | Hold |
3,118
| – | – | 0.01% | 753 |
|
|
2015
Q2 | $585K | Hold |
3,118
| – | – | 0.01% | 726 |
|
|
2015
Q1 | $514K | Hold |
3,118
| – | – | 0.01% | 769 |
|
|
2014
Q4 | $725K | Hold |
3,118
| – | – | 0.01% | 755 |
|
|
2014
Q3 | $564K | Sell |
3,118
-708
| -19% | -$128K | 0.01% | 779 |
|
|
2014
Q2 | $736K | Hold |
3,826
| – | – | 0.01% | 774 |
|
|
2014
Q1 | $696K | Sell |
3,826
-1,347
| -26% | -$245K | 0.01% | 760 |
|
|
2013
Q4 | $881K | Hold |
5,173
| – | – | 0.02% | 721 |
|
|
2013
Q3 | $811K | Hold |
5,173
| – | – | 0.01% | 728 |
|
|
2013
Q2 | $896K | Buy |
+5,173
| New | +$896K | 0.02% | 709 |
|